10-Q: Healthcare AI Acquisition Corp. Reports First Quarter 2024 Results Amidst Business Combination Pursuit

Healthcare AI Acquisition Corp. reports a net loss of $466,716 for the first quarter of 2024, while continuing its search for a business combination target.

Summary

• Healthcare AI Acquisition Corp. reported a net loss of $466,716 for the three months ended March 31, 2024, compared to a net loss of $225,709 for the same period in 2023.
• The company's operating costs were $87,533 for the quarter, a decrease from $397,932 in the prior year.
• Interest income from the trust account was $85,228, significantly lower than the $2,362,839 earned in the first quarter of 2023.
• A significant change in the fair value of warrant liabilities resulted in a loss of $464,411 for the quarter, compared to a loss of $2,190,616 in the same period last year.
• The company had $212 in cash on hand as of March 31, 2024, and $6,674,018 held in a trust account.
• The company has until December 14, 2024, to complete a business combination, and there is substantial doubt about its ability to continue as a going concern if a business combination is not completed by this date.
• The company has redeemed a significant number of shares, reducing the outstanding Class A shares to 591,851 and one Class B share.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the increased net loss, decreased interest income, the going concern warning, and the material weaknesses in internal controls. The company is facing significant challenges in completing a business combination and maintaining its financial stability.

Positives

• Operating costs decreased significantly year-over-year, indicating improved cost management.
• The company still holds a substantial amount of funds in its trust account, which can be used for a business combination.

Negatives

• The company reported a net loss of $466,716 for the quarter, an increase from the loss in the same period last year.
• Interest income from the trust account decreased significantly year-over-year.
• The change in fair value of warrant liabilities resulted in a significant loss.
• There is substantial doubt about the company's ability to continue as a going concern if a business combination is not completed by December 14, 2024.

Risks

• The company's ability to continue as a going concern is dependent on completing a business combination by December 14, 2024.
• Failure to complete a business combination will result in liquidation and dissolution.
• The company may not be able to raise additional capital if needed.
• The company's disclosure controls and procedures were not effective due to material weaknesses in analyzing complex financial instruments and recording accounts payable and accrued expenses.
• Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect the company's business.
• The company could be deemed an investment company, which would force liquidation.

Future Outlook

The company is focused on completing a business combination by December 14, 2024, but there is substantial doubt about its ability to continue as a going concern if this is not achieved. The company may seek additional capital through loans or other means.

Management Comments

• Management has determined that mandatory liquidation, and subsequent dissolution, should the Company be unable to complete a business combination, raises substantial doubt about the Company's ability to continue as a going concern for the next twelve months from the issuance of these financial statements.
• Management is currently evaluating the impact of the COVID-19 pandemic on the industry and has concluded that while it is reasonably possible that the virus could have a negative effect on the Company's financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements.

Industry Context

The report reflects the typical financial status of a SPAC in its search phase, with minimal operating activity and reliance on trust account interest. The company's focus is on identifying and completing a business combination within the given timeframe, which is a common challenge for SPACs.

Comparison to Industry Standards

• The financial results are typical for a SPAC in its pre-merger phase, with minimal operating revenue and reliance on interest income from the trust account.
• The significant fluctuations in warrant liability values are common for SPACs due to the nature of these instruments and their sensitivity to market conditions.
• The company's cash position and trust account balance are within the expected range for a SPAC of its size and stage.
• The going concern warning is not uncommon for SPACs approaching their deadline for completing a business combination, as many face similar time constraints and challenges in finding suitable targets.
• The redemption of a large number of shares is a common occurrence for SPACs, especially after extensions to the business combination deadline, as shareholders seek to recoup their investment.

Management Changes

Corporate Governance

Related Party Transactions

• The New Sponsor loaned the Company a total of $100,000 pursuant to a non-interest bearing and unsecured promissory note that is due upon closing of an initial Business Combination.
• The New Sponsor and New Sponsors shareholder loaned a total of $51,449 and $65,000 to the Company pursuant to a non-interest bearing and unsecured promissory note that is due upon closing of an initial Business Combination.
• The company had $303,330 borrowings under the New Sponsors Working Capital Loans as of March 31, 2024.

Stakeholder Impact

• Shareholders face the risk of liquidation if a business combination is not completed by December 14, 2024.
• Employees are impacted by the uncertainty surrounding the company's future.
• Creditors face the risk of not being paid if the company liquidates.
• The company's ability to complete a business combination will impact the value of the warrants.

Next Steps

• The company will continue to seek a suitable business combination target.
• The company may need to raise additional capital to fund operations and transaction costs.
• The company must address the material weaknesses in its internal controls.
• The company will need to complete a business combination by December 14, 2024, to avoid liquidation.

Key Dates

Keywords

SPAC, Business Combination, Healthcare AI Acquisition Corp, Warrant Liabilities, Trust Account, Redemption, Going Concern, Financial Results, Special Purpose Acquisition Company